Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma.
Correale P, Messinese S, Caraglia M, Marsili S, Piccolomini A, Petrioli R, Ceciarini F, Micheli L, Nencini C, Neri A, Vuolo G, Guarnieri A, Abbruzzese A, Prete SD, Giorgi G, Francini G. Correale P, et al. Among authors: marsili s. Br J Cancer. 2004 May 4;90(9):1710-4. doi: 10.1038/sj.bjc.6601783. Br J Cancer. 2004. PMID: 15150625 Free PMC article. Clinical Trial.
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer.
Correale P, Fulfaro F, Marsili S, Cicero G, Bajardi E, Intrivici C, Vuolo G, Carli AF, Caraglia M, Del Prete S, Greco E, Gebbia N, Francini G. Correale P, et al. Among authors: marsili s. Cancer Chemother Pharmacol. 2005 Dec;56(6):563-8. doi: 10.1007/s00280-005-1024-1. Epub 2005 Jul 23. Cancer Chemother Pharmacol. 2005. PMID: 16041610 Clinical Trial.
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients.
Correale P, Cusi MG, Tsang KY, Del Vecchio MT, Marsili S, Placa ML, Intrivici C, Aquino A, Micheli L, Nencini C, Ferrari F, Giorgi G, Bonmassar E, Francini G. Correale P, et al. Among authors: marsili s. J Clin Oncol. 2005 Dec 10;23(35):8950-8. doi: 10.1200/JCO.2005.12.147. Epub 2005 Aug 1. J Clin Oncol. 2005. PMID: 16061910 Clinical Trial.
Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer.
Petrioli R, Sabatino M, Roviello F, Marrelli D, Nastri G, Marsili S, Correale P, Pozzessere D, Messinese S, De Martino A, Tani F, Marzocca G, Lorenzi M, Civitelli S, Tanzini G, Pinto E, Francini G. Petrioli R, et al. Among authors: marsili s. Hepatogastroenterology. 2005 Sep-Oct;52(65):1626-30. Hepatogastroenterology. 2005. PMID: 16201130
Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin.
Petrioli R, Pascucci A, Francini E, Marsili S, Sciandivasci A, Tassi R, Civitelli S, Tanzini G, Lorenzi M, Francini G. Petrioli R, et al. Among authors: marsili s. Cancer Chemother Pharmacol. 2008 Jan;61(1):105-11. doi: 10.1007/s00280-007-0454-3. Epub 2007 Apr 12. Cancer Chemother Pharmacol. 2008. PMID: 17429632 Clinical Trial.
Weekly chemotherapy in advanced prostatic cancer.
Francini G, Petrioli R, Manganelli A, Cintorino M, Marsili S, Aquino A, Mondillo S. Francini G, et al. Among authors: marsili s. Br J Cancer. 1993 Jun;67(6):1430-6. doi: 10.1038/bjc.1993.265. Br J Cancer. 1993. PMID: 8512828 Free PMC article. Clinical Trial.
A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2.
Correale P, Micheli L, Vecchio MT, Sabatino M, Petrioli R, Pozzessere D, Marsili S, Giorgi G, Lozzi L, Neri P, Francini G. Correale P, et al. Among authors: marsili s. Br J Cancer. 2001 Nov 30;85(11):1722-30. doi: 10.1054/bjoc.2001.2136. Br J Cancer. 2001. PMID: 11742494 Free PMC article.
Weekly epirubicin in patients with hormone-resistant prostate cancer.
Petrioli R, Fiaschi AI, Pozzessere D, Messinese S, Sabatino M, Marsili S, Correale P, Manganelli A, Salvestrini F, Francini G. Petrioli R, et al. Among authors: marsili s. Br J Cancer. 2002 Sep 23;87(7):720-5. doi: 10.1038/sj.bjc.6600525. Br J Cancer. 2002. PMID: 12232753 Free PMC article. Clinical Trial.
88 results